EM-Tech Decides to Merge with Wholly-Owned Subsidiary BSL via Zero-Capital Increase

EM-Tech decides to absorb its wholly-owned subsidiary BSL in a small-scale merger
Zero-capital increase merger (no new shares issued); merger ratio 1:0 due to 100% ownership
BSL has negative equity of -₩34.96 billion and net loss of ₩1.39 billion as of end-2025
No change in EM-Tech's outstanding shares, capital, or major shareholder stake
Purpose: operational efficiency and healthcare synergy; no appraisal rights for shareholders
Shareholder approval replaced by board approval (small-scale merger); merger date July 24, 2026